Intermediate for Idelalisib. Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.
Product Name: (S)-tert-butyl 1-(5-Fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propylcarbamate
CAS Number: 870281-85-9
Molecular Weight:  397.4483
Molecular Formula:  C22H24FN3O3
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.
- Brands Tenova Pharmaceuticals
- Product Code: T31155
- Availability: In Stock
- Ex Tax: $415.00